COMMUNIQUÉS West-GlobeNewswire

Misonix to Present at the 43rd Annual Deutsche Bank Health Care Conference on May 8

23/04/2018 - 13:30

FARMINGDALE, N.Y., April 23, 2018 (GLOBE NEWSWIRE) -- Misonix, Inc. (NASDAQ: MSON ) (“Misonix” or the “Company”), a provider of minimally invasive therapeutic ultrasonic medical devices that enhance clinical outcomes, [...]

Melinta Therapeutics Presents Updates on the Pyrrolocytosine Compound RX-P2382 against ESKAPE Pathogens at ECCMID 2018

23/04/2018 - 13:30

NEW HAVEN, Conn., April 23, 2018 (GLOBE NEWSWIRE) -- Melinta Therapeutics, Inc. (NASDAQ: MLNT ), a commercial-stage company discovering, developing and commercializing novel antibiotics to treat serious bacterial [...]

Immunovaccine to Present at Bloom Burton & Co. Healthcare Investor Conference

23/04/2018 - 13:05

HALIFAX, Nova Scotia, April 23, 2018 (GLOBE NEWSWIRE) -- Immunovaccine Inc. (TSX: IMV ) (OTCQX:IMMVF), a clinical stage immuno-oncology company, announced that Chief Executive Officer Frederic Ors will present an update [...]

ObsEva Announces Upcoming Presentations Related to its Endometriosis and Uterine Fibroid Development Programs with its Novel Oral GnRH Receptor Antagonist OBE2109 (KLH-2109)

23/04/2018 - 13:01

Geneva, Switzerland and Boston, MA - 23 April 2018 - ObsEva SA (Nasdaq: OBSV), a Swiss biopharmaceutical company focused on the development and commercialization of novel therapeutics for serious conditions that [...]

Summit Highlights Discovery of New Mechanism Antibiotics for the Treatment of Gonorrhoea at ECCMID 2018

23/04/2018 - 13:00

Summit Therapeutics plc ("Summit" or the "Company") Summit Highlights Discovery of a Series of New Mechanism Antibiotics for the Treatment of Gonorrhoea in Late-Breaking Presentation at ECCMID 2018 Oxford, UK, and [...]

Kamada Received Feedback from FDA on Proposed Phase 3 Protocol for Inhaled Alpha-1-Antitrypsin for Treatment of Alpha-1 Antitrypsin Deficiency Disease

23/04/2018 - 13:00

REHOVOT, Israel, April 23, 2018 (GLOBE NEWSWIRE) -- Kamada Ltd. (the "Company") (Nasdaq: KMDA ) (TASE: KMDA ), a plasma-derived protein therapeutics company, today announced that the Company recently received feedback [...]

Zynerba Pharmaceuticals Announces Oral Presentation of ZYN002 Data at the 16th NFXF International Fragile X Conference in July 2018

23/04/2018 - 13:00

DEVON, Pa., April 23, 2018 (GLOBE NEWSWIRE) -- Zynerba Pharmaceuticals, Inc. (NASDAQ: ZYNE ), a clinical-stage specialty neuropsychiatric pharmaceutical company dedicated to developing and commercializing innovative [...]

Aclaris Therapeutics Announces First Patient Dosed in a Pilot Study with ATI-502 Topical in Patients with Androgenetic Alopecia

23/04/2018 - 13:00

WAYNE, Pa., April 23, 2018 (GLOBE NEWSWIRE) -- Aclaris Therapeutics, Inc. (NASDAQ: ACRS ), a dermatologist-led biopharmaceutical company committed to identifying, developing, and commercializing innovative therapies to [...]

Summit Highlights Discovery of a Series of New Mechanism Antibiotics for the Treatment of Gonorrhoea in Late-Breaking Presentation at ECCMID 2018

23/04/2018 - 13:00

OXFORD, United Kingdom and CAMBRIDGE, Mass., April 23, 2018 (GLOBE NEWSWIRE) -- Summit Therapeutics plc (NASDAQ: SMMT ) (AIM:SUMM) announces it highlighted the discovery of new mechanism antibiotic candidates for the [...]

Pluristem and Indiana University to Initiate Joint Project Evaluating PLX-R18 in Acute Radiation Syndrome, Targeting Bridging Data for Pivotal Study

23/04/2018 - 13:00

The 5-year joint project was granted $2.5 million from the U.S. National Institutes of Health (NIH) Data from these studies will support BLA filing for marketing approval of PLX-R18 in the treatment of ARS HAIFA, Israel [...]

Axsome Therapeutics Announces First Patient Enrolled in Phase 2 Clinical Trial of AXS-05 in Smoking Cessation

23/04/2018 - 13:00

Trial being conducted in collaboration with Duke University NEW YORK, April 23, 2018 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM ), a clinical-stage biopharmaceutical company developing novel therapies [...]

Annual Report 2017 Active Biotech AB (publ)

23/04/2018 - 11:31

PRESS RELEASE Active Biotech's Annual Report 2017 is now available för download at www.activebiotech.com . The Annual Report will only be digitally distributed. The English version will be available within short. Lund, [...]

Transactions under Novozymes’ stock buyback program

23/04/2018 - 11:15

Please read the full announcement in the attached PDF Attachment 2018_15_Stock_Buybackprogram_EN

Q Therapeutics Announces Joint Venture With REPROCELL

23/04/2018 - 11:00

PARTNERSHIP WILL DEVELOP IPSC-DERIVED PRODUCTS TO TREAT CENTRAL NERVOUS SYSTEM DISEASES INVOLVING DEMYELINATION AND DEGENERATION SALT LAKE CITY andI YOKOHAMA, Japan, April 23, 2018 (GLOBE NEWSWIRE) -- Q Therapeutics, [...]

Amarin Announces Promotion of Aaron Berg to Position of Chief Commercial Officer

23/04/2018 - 11:00

BEDMINSTER, N.J., and DUBLIN, Ireland, April 23, 2018 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ: AMRN ), a biopharmaceutical company focused on the commercialization and development of therapeutics to improve [...]

Share buy-back week 16/2018

23/04/2018 - 10:43

Announcement 23 April 2018 Coloplast – transactions in connection with share buy-back programme As mentioned in Announcement No. 3/2018 Coloplast has initiated the first part of the share buy-back programme totalling up [...]

Notice of Annual General Meeting in Acarix AB

23/04/2018 - 10:01

Press release April 23, 2018 Notice of Annual General Meeting in Acarix AB The shareholders of Acarix AB, reg. no. 559009-0667, (the " Company "), are hereby convened to the annual general meeting to be held on [...]

Reminder: C-RAD Web Presentation Interim Report Q1 2018

23/04/2018 - 09:30

Presentation of the report for the first quarter of the fiscal year 2018: Date: Thursday April 26, 2018 / kl. 11:00 Venue: Online Presentation Topic: C-RAD Interim Report Q1 2018 Procedure: Please register online [...]

Acarix publishes the annual report for 2017

23/04/2018 - 08:01

Press release from Acarix AB (publ) 2018-04-23 Acarix publishes the annual report for 2017 Today, Monday April 23, Acarix is publishing its Annual Report for 2017 on the company website www.acarix.com . The Annual [...]